Search - tctmd.com

Displaying 641 - 660 of 664

Sort: Relevancy | Date

News Daily News

Event Rates Often Overestimated in Cardiovascular Trials

Yael L. Maxwell

June 10, 2015

News Industry News

Amgen Completes Enrollment In Large Cardiovascular Outcomes Trial Of Repatha™ (Evolocumab) In Patients With High Cholesterol And Clinically Evident Cardiovascular Disease

June 05, 2015

News Industry News

Clinical Trial Demonstrates Elevated Thymosin Beta 4 Plasma Levels are Associated with Improvement of Symptoms After Stem Cell Therapy in Patients with Ischemic Heart Failure

June 02, 2015

News Industry News

Global Cardiovascular Drug Delivery Market 2015 - Technologies, Markets and Companies

May 28, 2015

News Industry News

Juventas Therapeutics Presents New 12-Month Data Demonstrating Single Administration of JVS-100 Improves Cardiac and Clinical Status in Patients with Severe Ischemic Heart Failure One Year After Treat

May 26, 2015

News Industry News

CVRx® Barostim Therapy® for Heart Failure Clinical Trial Results Presented in the Late-Breaking Clinical Trial Session of the Heart Rhythm Society 2015 Annual Conference

May 26, 2015

News Daily News

Long-term Ticagrelor Therapy Cost-Effective in US Patients

L.A. McKeown

February 02, 2015

News Daily News

La IC Empeora los Resultados Post-SCA No observándose Beneficio alguno con Apixaban

Todd Neale

January 28, 2015

News Daily News

‘Value’ of PCI Varies Widely Across VA Hospitals

Yael L. Maxwell

January 28, 2015

News Daily News

ASCERT Cost Analysis: CABG More Expensive Than PCI but Offers Better Outcomes

L.A. McKeown

January 12, 2015

News Daily News

Low Trial Participation Rate of MI Patients Raises Questions of Applicability

Todd Neale

September 02, 2014

News Daily News

PCI Efficacy Unaffected by HIV Status

Yael L. Maxwell

July 07, 2014

News Daily News

Prognosis Poor for Primary PCI Patients with Cardiac Arrest Before Ambulance Arrival

L.A. McKeown

May 16, 2014

News Daily News

Risk Score Predicts Long-term Mortality After PCI

Caitlin E. Cox

February 03, 2014

News Conference News TCT 2013

Innovation in Intervention: Perspectives from Industry

October 30, 2013

News Daily News

FAME 2: La PCI Guiada por FFR resulta ‘Atractiva Económicamente’ comparada con Solo el Tratamiento Médico

Caitlin E. Cox

August 30, 2013

News Daily News

For Inoperable Patients, TAVR Carries Benefits but Raises Lifetime Costs

July 25, 2013

News Conference News AHA 2012

AHA 2012: Multiple Studies Provide Clinical Guidance for Interventional Community

Jason Kahn

November 11, 2012

News Daily News

Halving DES Use in Low-Risk Patients Could Save $200 Million Annually

Yael L. Maxwell

July 11, 2012

News Daily News

Tanto el Coste como la Calidad del Tratamiento de la EAP Depende del Personal Médico al Cargo

Yael L. Maxwell

March 06, 2012

Advertisement

Event Rates Often Overestimated in Cardiovascular Trials

Amgen Completes Enrollment In Large Cardiovascular Outcomes Trial Of Repatha™ (Evolocumab) In Patients With High Cholesterol And Clinically Evident Cardiovascular Disease

Clinical Trial Demonstrates Elevated Thymosin Beta 4 Plasma Levels are Associated with Improvement of Symptoms After Stem Cell Therapy in Patients with Ischemic Heart Failure

Global Cardiovascular Drug Delivery Market 2015 - Technologies, Markets and Companies

Juventas Therapeutics Presents New 12-Month Data Demonstrating Single Administration of JVS-100 Improves Cardiac and Clinical Status in Patients with Severe Ischemic Heart Failure One Year After Treat

CVRx® Barostim Therapy® for Heart Failure Clinical Trial Results Presented in the Late-Breaking Clinical Trial Session of the Heart Rhythm Society 2015 Annual Conference

Long-term Ticagrelor Therapy Cost-Effective in US Patients

La IC Empeora los Resultados Post-SCA No observándose Beneficio alguno con Apixaban

‘Value’ of PCI Varies Widely Across VA Hospitals

ASCERT Cost Analysis: CABG More Expensive Than PCI but Offers Better Outcomes

Low Trial Participation Rate of MI Patients Raises Questions of Applicability

PCI Efficacy Unaffected by HIV Status

Prognosis Poor for Primary PCI Patients with Cardiac Arrest Before Ambulance Arrival

Risk Score Predicts Long-term Mortality After PCI

Innovation in Intervention: Perspectives from Industry

FAME 2: La PCI Guiada por FFR resulta ‘Atractiva Económicamente’ comparada con Solo el Tratamiento Médico

For Inoperable Patients, TAVR Carries Benefits but Raises Lifetime Costs

AHA 2012: Multiple Studies Provide Clinical Guidance for Interventional Community

Halving DES Use in Low-Risk Patients Could Save $200 Million Annually

Tanto el Coste como la Calidad del Tratamiento de la EAP Depende del Personal Médico al Cargo

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content